Developer docs
API playgroundTry for free, no card

Search company profiles

iNova Pharmaceuticals

Full company profile

uuid0008li5

Namestring
iNova Pharmaceuticals
Legal namestring
iNova Pharmaceuticals
Websiteurl
inovapharma.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

iNova Pharmaceuticals is a Singapore-domiciled, privately held consumer healthcare and prescription medicines company that develops, markets, and distributes a portfolio of over 20 heritage brands across 75+ international markets spanning Asia-Pacific, the Middle East, Africa, Europe, and select North American markets. Its consumer healthcare portfolio is anchored by long-standing brands including BETADINE (povidone-iodine antiseptics), Difflam (throat care), Duro-Tuss (cough), Demazin (cold and flu), DermaVeen (dermatology), and Acne-Aid, alongside regional brands such as Gold Cross, Nyal, Creche Guard, Andolex, B-CAL, Invisible Zinc, and Reef. The prescription medicines portfolio spans weight management (Contrave, Duromine), pain, cardiology, respiratory (Airomir, Qvar, Nuelin), and dermatology (Aldara, Efudix). The company's core technology is consumer healthcare formulation science — proprietary combinations including povidone-iodine antiseptic systems, benzydamine-based anti-inflammatory throat formulations, and therapeutic cough and dermatological preparations — rather than novel drug discovery.

iNova operates a multi-channel go-to-market model: branded OTC products are sold primarily through retail pharmacy chains and independent pharmacies (including named partner Chemist Warehouse in Australia), supported by 13+ regional offices in Singapore (global HQ), Chatswood (Australia), Hong Kong, Kuala Lumpur, Manila, Bangkok, Jakarta, Dubai, Johannesburg, Cairo, Auckland (via Radiant Health subsidiary), Dublin, and Zug. Distribution to healthcare providers for prescription medicines is managed through a regional field sales structure, while brand extension into new markets is supported by licensing partners such as Lavipharm. The business model is straightforward product sale through retail and pharmacy channels, supplemented by in-licensing and brand acquisition as the primary portfolio expansion mechanism. Growth has been largely inorganic: iNova was acquired by Valeant in 2011, by Pacific Equity Partners and Carlyle in 2017, and by TPG (majority), Pacific Equity Partners, and Platinum Orchid/ADIA in 2022, with subsequent add-on acquisitions including Demazin (2019), Radiant Health and Acne-Aid (2020), and the transformational Mundipharma International consumer health portfolio including BETADINE in 2024.

Short descriptiontext

iNova Pharmaceuticals is a Singapore-domiciled, PE-backed consumer healthcare company that develops, markets, and distributes a portfolio of 20+ heritage OTC and prescription brands including BETADINE, Difflam, Duro-Tuss, and Demazin across 75+ markets in Asia-Pacific, the Middle East, Africa, and Europe, primarily through retail pharmacy and healthcare provider channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersChatswood, Australia
HQ citystring
Chatswood
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
consumer healthcare products, prescription medicines, over-the-counter medicines, antiseptic wound care, throat care remedies
Industry5 codes
1Specialty Care Pharmaceuticals
CodeHLAIAAABPrimaryYes
2Dermatology & Aesthetics Pharmaceuticals
CodeHLAIAAAKPrimaryNo
3Respiratory & Allergy Pharmaceuticals
CodeHLAIAAAHPrimaryNo
4Gastroenterology & Hepatology Pharmaceuticals
CodeHLAIAAAIPrimaryNo
5Pulmonology & Allergy Specialty Pharmaceuticals
CodeHLAIACAFPrimaryNo
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Consumer Healthcare Pharmaceuticals
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Consumer Healthcare Products
TypeOne Time License
Description

Sale of over-the-counter consumer healthcare products including analgesics, throat/cold remedies, antiseptic wound care, dermatology products, and cough medicines through retail pharmacies across 75+ markets

inovapharma.com
2Prescription Medicines
TypeOne Time License
Description

Prescription pharmaceutical products sold through healthcare providers and pharmacies

inovapharma.com
3Brand Licensing and Acquisitions
TypeLicensing Royalties
Description

Revenue generated through in-licensing, acquisition, and licensing out of established consumer health brands across global markets

naftemporiki.gr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 20 records shown
1BETADINE
Description

Wound care brand trusted by healthcare professionals worldwide for over 60 years. Products include antiseptic solutions for wound care, sore throat relief, and feminine care.

inovapharma.com
+19 more records
Core offering1 text field

iNova Pharmaceuticals develops, markets and distributes a portfolio of trusted branded consumer healthcare products (including wound care antiseptics, throat/cough/cold/flu remedies, dermatology and sun care, natural health supplements, and medicine cabinet essentials) and prescription medicines across weight management, pain management, dermatology, respiratory and cardiology categories. The company sells these products across more than 75 markets via retail pharmacy networks, healthcare providers and brand licensing partners, with an active acquisition and in-licensing strategy to expand its brand portfolio and geographic reach.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

iNova Pharmaceuticals is a consumer healthcare company offering a broad portfolio of trusted brands across Consumer Healthcare and Prescription Medicines. The Consumer Healthcare portfolio includes: Throat, Cough, Cold & Flu brands (BETADINE, Difflam, DURO-TUSS, Demazin, Valda, Andolex, Dequadin); Wound Care (BETADINE); Skin Health & Sun Protection (DermaVeen, Acne-Aid, Invisible Zinc, Reef); Natural Health supplements (Senokot, Creche Guard, PregOmega Plus, B-CAL, Ferrous Forte, StaminoGro); and Medicine Cabinet Essentials (Nyal, Gold Cross, Hiprex). The Prescription Medicines portfolio spans Weight Management (Contrave, Duromine), Pain Management (various), Heart Health, Dermatology (Aldara, Efudix, ReTreive), and Respiratory Health (Airomir, Qvar, Nuelin). Products are available across 75+ markets globally with regional offices in Asia-Pacific, Middle East, Africa and Europe.

Product and service21 records
1BETADINE
CategoryWound Care Antiseptics
Description

BETADINE is a trusted antiseptic brand containing povidone-iodine, offering wound care solutions, sore throat relief products, and feminine care products. Available globally in multiple formats including solutions, gargles, sprays, and lozenges, trusted by healthcare professionals worldwide for over 60 years.

2Difflam
CategoryThroat Care Remedies
Description

Difflam is a leading sore throat brand in Asia-Pacific with over 30 years of history, offering lollipops, lozenges, sprays, solutions and gargles for sore throat relief. Products include Difflam Kids Soothing Throat Pops with Wellmune for immune health support.

3DURO-TUSS
CategoryCough Remedies
Description

DURO-TUSS is a trusted cough relief brand for over 25 years in Asia-Pacific, available as syrups, tablets and lozenges for chesty coughs, dry coughs, and children's coughs.

4Demazin
CategoryCold and Flu Remedies
Description

Demazin is a trusted cold and flu brand trusted by families for over 50 years in Australia, offering products for colds, coughs, nasal congestion, and hayfever relief with a comprehensive kids range.

5DermaVeen
CategorySkin Health and Sun Protection
Description

DermaVeen is a dermatologist-recommended skincare brand formulated with 100% natural OatActiv+, offering hypoallergenic body, face, hair, sun and baby products for dry, itchy and sensitive skin.

6Acne-Aid
CategorySkin Health and Sun Protection
Description

Acne-Aid offers a range of effective products for oily and acne-prone skin including cleansers, lotions and remedies targeting oil control and sensitive skin. Trusted across Asia with 99% user recommendation rate.

7Nyal
CategoryMedicine Cabinet Essentials
Description

Nyal is a family favourite medicine cabinet brand trusted since 1911, providing medicines for pain relief, coughs, cold and flu, nasal congestion and mouth health in Australia.

8Senokot
CategoryNatural Health Supplements
Description

Senokot is a gentle laxative made from senna plant leaves and fruit, providing overnight relief from occasional constipation for over 60 years.

9Valda
CategoryThroat Care Remedies
Description

Valda offers pastilles and hard candy for throat relief with a mega-hit of menthol, available in Original Lemon, Lemon Menthol, Citrus Menthol and Himalayan Salt and Lemon Menthol flavors.

10Gold Cross
CategoryMedicine Cabinet Essentials
Description

Gold Cross is a respected pharmacy-only brand trusted for over 70 years, providing medicines for coughs, colds, skin irritations, cuts, abrasions, digestive complaints, muscle and joint relief, and vitamin supplementation.

11PregOmega Plus
CategoryNatural Health Supplements
Description

PregOmega Plus is South Africa's number one prenatal 3-in-1 combination supplement containing Folate, Calcium, Iron, B-vitamins, Vitamin D, Vitamin A and Omega 3 for before, during and after pregnancy.

12Creche Guard
CategoryNatural Health Supplements
Description

Creche Guard is South Africa's Number 1 Children's Multivitamin and Mineral Supplement offering Immune Multivitamin products with Zinc, Vitamin D and Vitamin C, and a Probiotic range including oral sprays, drops, and chocolate bars.

13Andolex
CategoryThroat Care Remedies
Description

Andolex is South Africa's leading brand for sore throat and mouth, offering throat sprays, sore throat lozenges, dry mouth pastilles, throat lollies, oral rinses and oral gel with anti-bacterial and antiseptic properties.

14Dequadin
CategoryThroat Care Remedies
Description

Dequadin is a medicated sore throat relief brand that effectively kills germs and soothes the throat, with a non-medicated range delivering refreshment with menthol.

15B-CAL
CategoryNatural Health Supplements
Description

B-CAL is South Africa's No. 1 prescribed and best-selling calcium range offering bone health supplements including B-CAL-K2 (5-in-1 with Calcium, Vitamin D3, Magnesium, Vitamin K2, Vitamin C) and B-CAL-DM.

16Ferrous Forte
CategoryNatural Health Supplements
Description

Ferrous Forte is a combination iron supplement containing iron bisglycinate for better absorption with Folic Acid, Vitamin B12, and Vitamin C to help form healthy red blood cells and hemoglobin.

17StaminoGro
CategoryNatural Health Supplements
Description

StaminoGro is a 5-in-1 combination supplement with amino acids, antioxidants, B-vitamins, Calcium and other vitamins and minerals to promote energy, well-being, immune defence and mental vitality. Includes StaminoGro Woman variant with added Iron and Folic Acid.

18Hiprex
CategoryMedicine Cabinet Essentials
Description

Hiprex is used for prevention or suppression of bacteria in the urine that can cause chronic or recurrent urinary tract infections (UTIs).

19Invisible Zinc
CategorySkin Health and Sun Protection
Description

Invisible Zinc is Australia's leading zinc sunscreen brand offering broad range of high SPF products using naturally sourced Zinc Oxide to create a physical barrier reflecting UVA and UVB rays.

20Reef
CategorySkin Health and Sun Protection
Description

Reef is one of Australia's most iconic sun care brands since the 1970s, featuring coconut scented skincare oils and SPF suncare products formulated with Almond Oil and Coconut Oil.

21Prescription Medicines Portfolio
CategoryPrescription Medicines
Description

iNova offers prescription medicines across cardiology, pain management, weight management, allergy, dermatology and respiratory health including Airomir, Aldara, Contrave, Duromine, Efudix, Lomotil, Maxolon, Nuelin, Qvar, Rikodeine, and others.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic agreement with Lavipharm for brand development and distribution partnership, leveraging Lavipharm's regional pharmaceutical expertise and distribution capabilities.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Chemist Warehouse is a major retail pharmacy partner for iNova products in Australia, including participation in blister pack recycling initiative with Pharmacycle.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Pharmacycle for blister pack recycling initiative, demonstrating iNova's commitment to sustainability through responsible packaging disposal.

Strategic tierMinorTypeOthers
Description

White & Case LLP served as legal advisors for iNova's refinancing transaction, providing legal counsel on the financing structure.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

London-listed global consumer healthcare pure-play (spun from GSK in 2022) with leading OTC brands across pain, oral health, vitamins and respiratory. Direct competitor to iNova in categories like sore throat, cough/cold and dermatology, and a credible exit acquirer for iNova.

TypeRegional player
Description

Japan-listed OTC and prescription pharmaceutical company with strong consumer health brands (Lipovitan, RiUP). Comparable as an Asia-focused branded OTC and prescription operator with regional brand portfolios.

TypeBroad incumbent
Description

Global consumer health major with leading OTC brands (Strepsils, Nurofen, Gaviscon, Dettol). Strepsils is a direct competitor to Difflam in the sore throat category across APAC and the Middle East.

TypeRegional player
Description

South African pharmaceutical major with both branded consumer health and prescription portfolios across Africa. Comparable footprint, regulatory profile and OTC/prescription mix to iNova's South African business.

TypeBroad incumbent
Description

Bayer's consumer health unit with brands including Claritin, Aspirin, Canesten and Bepanthen. Competes with iNova across allergy, dermatology and wound care; Andrew Jenkin (iNova President CANZ & SA) previously held senior roles at Bayer.

TypeBroad incumbent
Description

Johnson & Johnson's former consumer health division, now independent, with global OTC and personal care brands (Tylenol, Zyrtec, Neutrogena, Aveeno). Direct competitor to iNova in dermatology (DermaVeen vs. Aveeno) and OTC categories, and a likely strategic acquirer.

TypeRegional player
Description

South Korean pharmaceutical and consumer healthcare company with OTC, dermatology and prescription medicines. Comparable as a regional branded pharma operator with strong APAC and emerging-market presence.

TypeRegional player
Description

South African-listed pharmaceutical and consumer health company. Direct peer in South Africa across OTC and prescription categories; iNova's Global Head of Medical Affairs Kym Hampton previously held senior roles at Adcock Ingram.

TypeBroad incumbent
Description

Global pharmaceutical major with a sizable consumer health division (Allegra, Dulcolax, Gold Bond). Competes with iNova in allergy (Demazin), laxatives (Senokot) and dermatology categories.

TypeOthers
Description

Independent pharmaceutical network from which iNova acquired the BETADINE-anchored consumer health portfolio in 2024. Retained prescription and other operations make Mundipharma an adjacent ecosystem participant rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iNova Pharmaceuticals

Consumer Healthcare Pharmaceuticalsinovapharma.com

iNova Pharmaceuticals is a Singapore-domiciled, PE-backed consumer healthcare company that develops, markets, and distributes a portfolio of 20+ heritage OTC and prescription brands including BETADINE, Difflam, Duro-Tuss, and Demazin across 75+ markets in Asia-Pacific, the Middle East, Africa, and Europe, primarily through retail pharmacy and healthcare provider channels.

What iNova Pharmaceuticals does

iNova Pharmaceuticals is a Singapore-domiciled, privately held consumer healthcare and prescription medicines company that develops, markets, and distributes a portfolio of over 20 heritage brands across 75+ international markets spanning Asia-Pacific, the Middle East, Africa, Europe, and select North American markets. Its consumer healthcare portfolio is anchored by long-standing brands including BETADINE (povidone-iodine antiseptics), Difflam (throat care), Duro-Tuss (cough), Demazin (cold and flu), DermaVeen (dermatology), and Acne-Aid, alongside regional brands such as Gold Cross, Nyal, Creche Guard, Andolex, B-CAL, Invisible Zinc, and Reef. The prescription medicines portfolio spans weight management (Contrave, Duromine), pain, cardiology, respiratory (Airomir, Qvar, Nuelin), and dermatology (Aldara, Efudix). The company's core technology is consumer healthcare formulation science — proprietary combinations including povidone-iodine antiseptic systems, benzydamine-based anti-inflammatory throat formulations, and therapeutic cough and dermatological preparations — rather than novel drug discovery.

iNova operates a multi-channel go-to-market model: branded OTC products are sold primarily through retail pharmacy chains and independent pharmacies (including named partner Chemist Warehouse in Australia), supported by 13+ regional offices in Singapore (global HQ), Chatswood (Australia), Hong Kong, Kuala Lumpur, Manila, Bangkok, Jakarta, Dubai, Johannesburg, Cairo, Auckland (via Radiant Health subsidiary), Dublin, and Zug. Distribution to healthcare providers for prescription medicines is managed through a regional field sales structure, while brand extension into new markets is supported by licensing partners such as Lavipharm. The business model is straightforward product sale through retail and pharmacy channels, supplemented by in-licensing and brand acquisition as the primary portfolio expansion mechanism. Growth has been largely inorganic: iNova was acquired by Valeant in 2011, by Pacific Equity Partners and Carlyle in 2017, and by TPG (majority), Pacific Equity Partners, and Platinum Orchid/ADIA in 2022, with subsequent add-on acquisitions including Demazin (2019), Radiant Health and Acne-Aid (2020), and the transformational Mundipharma International consumer health portfolio including BETADINE in 2024.

iNova Pharmaceuticals firmographics

Firmographics
Name
iNova Pharmaceuticals
Legal name
iNova Pharmaceuticals
Website
https://inovapharma.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
251–500 employees
Short description
iNova Pharmaceuticals is a Singapore-domiciled, PE-backed consumer healthcare company that develops, markets, and distributes a portfolio of 20+ heritage OTC and prescription brands including BETADINE, Difflam, Duro-Tuss, and Demazin across 75+ markets in Asia-Pacific, the Middle East, Africa, and Europe, primarily through retail pharmacy and healthcare provider channels.
Ownership category
akta.pro rank

iNova Pharmaceuticals industry classification

Industry
Product category
Consumer Healthcare Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Specialty Care Pharmaceuticals (HLAIAAAB)
akta.pro secondary industries
Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Respiratory & Allergy Pharmaceuticals (HLAIAAAH), Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

  • Consumer healthcare products
  • Prescription medicines
  • Over-the-counter medicines
  • Antiseptic wound care
  • Throat care remedies

Where iNova Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Chatswood
HQ country
Australia
HQ region
Oceania

Offices13 records

Markets served

iNova Pharmaceuticals business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Consumer Healthcare Products: Sale of over-the-counter consumer healthcare products including analgesics, throat/cold remedies, antiseptic wound care, dermatology products, and cough medicines through retail pharmacies across 75+ markets
  2. Prescription Medicines: Prescription pharmaceutical products sold through healthcare providers and pharmacies
  3. Brand Licensing and Acquisitions: Revenue generated through in-licensing, acquisition, and licensing out of established consumer health brands across global markets

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

iNova Pharmaceuticals product offering

Product offering

Core offering

iNova Pharmaceuticals develops, markets and distributes a portfolio of trusted branded consumer healthcare products (including wound care antiseptics, throat/cough/cold/flu remedies, dermatology and sun care, natural health supplements, and medicine cabinet essentials) and prescription medicines across weight management, pain management, dermatology, respiratory and cardiology categories. The company sells these products across more than 75 markets via retail pharmacy networks, healthcare providers and brand licensing partners, with an active acquisition and in-licensing strategy to expand its brand portfolio and geographic reach.

Product overview

iNova Pharmaceuticals is a consumer healthcare company offering a broad portfolio of trusted brands across Consumer Healthcare and Prescription Medicines. The Consumer Healthcare portfolio includes: Throat, Cough, Cold & Flu brands (BETADINE, Difflam, DURO-TUSS, Demazin, Valda, Andolex, Dequadin); Wound Care (BETADINE); Skin Health & Sun Protection (DermaVeen, Acne-Aid, Invisible Zinc, Reef); Natural Health supplements (Senokot, Creche Guard, PregOmega Plus, B-CAL, Ferrous Forte, StaminoGro); and Medicine Cabinet Essentials (Nyal, Gold Cross, Hiprex). The Prescription Medicines portfolio spans Weight Management (Contrave, Duromine), Pain Management (various), Heart Health, Dermatology (Aldara, Efudix, ReTreive), and Respiratory Health (Airomir, Qvar, Nuelin). Products are available across 75+ markets globally with regional offices in Asia-Pacific, Middle East, Africa and Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • BETADINE: Wound care brand trusted by healthcare professionals worldwide for over 60 years. Products include antiseptic solutions for wound care, sore throat relief, and feminine care.
  • Difflam
  • Duro-Tuss
  • Demazin
  • DermaVeen
  • Acne-Aid
  • Nyal
  • Senokot
  • Valda
  • Gold Cross
  • Invisible Zinc
  • Reef
  • Creche Guard
  • Andolex
  • Dequadin
  • B-CAL
  • StaminoGro
  • Ferrous Forte
  • PregOmega Plus
  • Hiprex

Products and services

  • BETADINE BETADINE is a trusted antiseptic brand containing povidone-iodine, offering wound care solutions, sore throat relief products, and feminine care products. Available globally in multiple formats including solutions, gargles, sprays, and lozenges, trusted by healthcare professionals worldwide for over 60 years.
  • Difflam Difflam is a leading sore throat brand in Asia-Pacific with over 30 years of history, offering lollipops, lozenges, sprays, solutions and gargles for sore throat relief. Products include Difflam Kids Soothing Throat Pops with Wellmune for immune health support.
  • DURO-TUSS DURO-TUSS is a trusted cough relief brand for over 25 years in Asia-Pacific, available as syrups, tablets and lozenges for chesty coughs, dry coughs, and children's coughs.
  • Demazin Demazin is a trusted cold and flu brand trusted by families for over 50 years in Australia, offering products for colds, coughs, nasal congestion, and hayfever relief with a comprehensive kids range.
  • DermaVeen DermaVeen is a dermatologist-recommended skincare brand formulated with 100% natural OatActiv+, offering hypoallergenic body, face, hair, sun and baby products for dry, itchy and sensitive skin.
  • Acne-Aid Acne-Aid offers a range of effective products for oily and acne-prone skin including cleansers, lotions and remedies targeting oil control and sensitive skin. Trusted across Asia with 99% user recommendation rate.
  • Nyal Nyal is a family favourite medicine cabinet brand trusted since 1911, providing medicines for pain relief, coughs, cold and flu, nasal congestion and mouth health in Australia.
  • Senokot Senokot is a gentle laxative made from senna plant leaves and fruit, providing overnight relief from occasional constipation for over 60 years.
  • Valda Valda offers pastilles and hard candy for throat relief with a mega-hit of menthol, available in Original Lemon, Lemon Menthol, Citrus Menthol and Himalayan Salt and Lemon Menthol flavors.
  • Gold Cross Gold Cross is a respected pharmacy-only brand trusted for over 70 years, providing medicines for coughs, colds, skin irritations, cuts, abrasions, digestive complaints, muscle and joint relief, and vitamin supplementation.
  • PregOmega Plus PregOmega Plus is South Africa's number one prenatal 3-in-1 combination supplement containing Folate, Calcium, Iron, B-vitamins, Vitamin D, Vitamin A and Omega 3 for before, during and after pregnancy.
  • Creche Guard Creche Guard is South Africa's Number 1 Children's Multivitamin and Mineral Supplement offering Immune Multivitamin products with Zinc, Vitamin D and Vitamin C, and a Probiotic range including oral sprays, drops, and chocolate bars.
  • Andolex Andolex is South Africa's leading brand for sore throat and mouth, offering throat sprays, sore throat lozenges, dry mouth pastilles, throat lollies, oral rinses and oral gel with anti-bacterial and antiseptic properties.
  • Dequadin Dequadin is a medicated sore throat relief brand that effectively kills germs and soothes the throat, with a non-medicated range delivering refreshment with menthol.
  • B-CAL B-CAL is South Africa's No. 1 prescribed and best-selling calcium range offering bone health supplements including B-CAL-K2 (5-in-1 with Calcium, Vitamin D3, Magnesium, Vitamin K2, Vitamin C) and B-CAL-DM.
  • Ferrous Forte Ferrous Forte is a combination iron supplement containing iron bisglycinate for better absorption with Folic Acid, Vitamin B12, and Vitamin C to help form healthy red blood cells and hemoglobin.
  • StaminoGro StaminoGro is a 5-in-1 combination supplement with amino acids, antioxidants, B-vitamins, Calcium and other vitamins and minerals to promote energy, well-being, immune defence and mental vitality. Includes StaminoGro Woman variant with added Iron and Folic Acid.
  • Hiprex Hiprex is used for prevention or suppression of bacteria in the urine that can cause chronic or recurrent urinary tract infections (UTIs).
  • Invisible Zinc Invisible Zinc is Australia's leading zinc sunscreen brand offering broad range of high SPF products using naturally sourced Zinc Oxide to create a physical barrier reflecting UVA and UVB rays.
  • Reef Reef is one of Australia's most iconic sun care brands since the 1970s, featuring coconut scented skincare oils and SPF suncare products formulated with Almond Oil and Coconut Oil.
  • Prescription Medicines Portfolio iNova offers prescription medicines across cardiology, pain management, weight management, allergy, dermatology and respiratory health including Airomir, Aldara, Contrave, Duromine, Efudix, Lomotil, Maxolon, Nuelin, Qvar, Rikodeine, and others.

Companies that use iNova Pharmaceuticals

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

iNova Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

iNova Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core, major and minor.

  • LavipharmcoreStrategic or Co-development PartnerStrategic agreement with Lavipharm for brand development and distribution partnership, leveraging Lavipharm's regional pharmaceutical expertise and distribution capabilities.
  • Chemist WarehousemajorChannel Partner/ Reseller/ DistributorChemist Warehouse is a major retail pharmacy partner for iNova products in Australia, including participation in blister pack recycling initiative with Pharmacycle.
  • PharmacycleminorStrategic or Co-development PartnerPartnership with Pharmacycle for blister pack recycling initiative, demonstrating iNova's commitment to sustainability through responsible packaging disposal.
  • White & Case LLPminorOthersWhite & Case LLP served as legal advisors for iNova's refinancing transaction, providing legal counsel on the financing structure.

Scale indicators3 records

Recent moves10 records

Expansion highlights6 records

iNova Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Haleon: London-listed global consumer healthcare pure-play (spun from GSK in 2022) with leading OTC brands across pain, oral health, vitamins and respiratory. Direct competitor to iNova in categories like sore throat, cough/cold and dermatology, and a credible exit acquirer for iNova.

Regional players

  • Taisho Pharmaceutical: Japan-listed OTC and prescription pharmaceutical company with strong consumer health brands (Lipovitan, RiUP). Comparable as an Asia-focused branded OTC and prescription operator with regional brand portfolios.
  • Aspen Pharmacare: South African pharmaceutical major with both branded consumer health and prescription portfolios across Africa. Comparable footprint, regulatory profile and OTC/prescription mix to iNova's South African business.
  • Daewoong Pharmaceutical: South Korean pharmaceutical and consumer healthcare company with OTC, dermatology and prescription medicines. Comparable as a regional branded pharma operator with strong APAC and emerging-market presence.
  • Adcock Ingram: South African-listed pharmaceutical and consumer health company. Direct peer in South Africa across OTC and prescription categories; iNova's Global Head of Medical Affairs Kym Hampton previously held senior roles at Adcock Ingram.

Broad incumbents

  • Reckitt Benckiser: Global consumer health major with leading OTC brands (Strepsils, Nurofen, Gaviscon, Dettol). Strepsils is a direct competitor to Difflam in the sore throat category across APAC and the Middle East.
  • Bayer Consumer Health: Bayer's consumer health unit with brands including Claritin, Aspirin, Canesten and Bepanthen. Competes with iNova across allergy, dermatology and wound care; Andrew Jenkin (iNova President CANZ & SA) previously held senior roles at Bayer.
  • Kenvue: Johnson & Johnson's former consumer health division, now independent, with global OTC and personal care brands (Tylenol, Zyrtec, Neutrogena, Aveeno). Direct competitor to iNova in dermatology (DermaVeen vs. Aveeno) and OTC categories, and a likely strategic acquirer.
  • Sanofi Consumer Healthcare: Global pharmaceutical major with a sizable consumer health division (Allegra, Dulcolax, Gold Bond). Competes with iNova in allergy (Demazin), laxatives (Senokot) and dermatology categories.

Others

  • Mundipharma: Independent pharmaceutical network from which iNova acquired the BETADINE-anchored consumer health portfolio in 2024. Retained prescription and other operations make Mundipharma an adjacent ecosystem participant rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

iNova Pharmaceuticals social profiles

Digital presence

iNova Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iNova Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles11 records

iNova Pharmaceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

iNova Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iNova Pharmaceuticals M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iNova Pharmaceuticals

What does iNova Pharmaceuticals do?

iNova Pharmaceuticals develops, markets and distributes a portfolio of trusted branded consumer healthcare products (including wound care antiseptics, throat/cough/cold/flu remedies, dermatology and sun care, natural health supplements, and medicine cabinet essentials) and prescription medicines across weight management, pain management, dermatology, respiratory and cardiology categories. The company sells these products across more than 75 markets via retail pharmacy networks, healthcare providers and brand licensing partners, with an active acquisition and in-licensing strategy to expand its brand portfolio and geographic reach.

Is iNova Pharmaceuticals a public or private company?

iNova Pharmaceuticals is a private company. It is classified as private equity controlled and is currently operating.

When was iNova Pharmaceuticals founded?

iNova Pharmaceuticals was founded in 2006. It employs 251 to 500 people.

Where is iNova Pharmaceuticals based?

iNova Pharmaceuticals is headquartered in Chatswood, Australia, in the Oceania region.

How does iNova Pharmaceuticals make money?

Three revenue lines are on record. Consumer Healthcare Products are the primary driver. The others are prescription Medicines and brand Licensing and Acquisitions.

Who are iNova Pharmaceuticals's main competitors?

Haleon is listed as a direct peer. Regional players are Taisho Pharmaceutical, Aspen Pharmacare, Daewoong Pharmaceutical and Adcock Ingram. Broad incumbents are Reckitt Benckiser, Bayer Consumer Health, Kenvue and Sanofi Consumer Healthcare. Mundipharma is listed as an others.

Does iNova Pharmaceuticals have an API?

No public API is recorded for iNova Pharmaceuticals.

What industry is iNova Pharmaceuticals in?

iNova Pharmaceuticals's product category is Consumer Healthcare Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Retail PharmacyiNova Pharmaceuticals announces new partnership with Chemist Warehouse and Pharmacycle’s in-store blister pack recycling initiativeiNova Pharmaceuticals has partnered with Chemist Warehouse and Pharmacycle to join their existing blister pack recycling initiative, supporting the collection and recycling of blister packs in all Chemist Warehouse pharmacies across Australia. To date, the program has recycled 50 million blister packs, addressing the challenge that blister packs cannot be recycled through kerbside programs due to their mixed plastic and aluminum composition. The partnership aims to expand sustainable healthcare practices and reduce pharmaceutical packaging waste going into landfill.LinkedIniNova PharmaceuticalsThe provided text consists of multiple unrelated social media posts from iNova Pharmaceuticals covering employee spotlights, corporate social responsibility initiatives, and award announcements. The content includes a recruitment post for an Assistant Supply Chain Manager in Bangkok, advocacy for antimicrobial resistance awareness during World AMR Awareness Week, participation in Singapore's Plant-A-Tree Programme, and recognition at the Asia eCommerce Awards 2025.aipia.infoInova Pharmaceuticals (S) Pte LtdiNova Pharmaceuticals is an international organization that develops, markets, and sells prescription medicines and consumer health products across Asia, Australia, New Zealand, and Africa. The company employs over 500 professionals and focuses on product innovation and business development following a change of ownership in late 2017.Financial PostTPG-Backed Inova Agrees to Acquire Mundipharma's OTC BusinessTPG-backed iNova Pharmaceuticals has agreed to acquire Mundipharma International Ltd.'s over-the-counter consumer health business for approximately $540 million. The transaction primarily involves the Betadine product franchise and will proceed with proceeds held in escrow to support resolution of legal claims related to the Sackler family's opioid crisis liabilities. The deal is subject to regulatory approval.TpgTPG Capital Asia Completes Investment in iNova PharmaceuticalsTPG Capital Asia has completed a majority investment in iNova Pharmaceuticals, a consumer healthcare company operating across Asia, Australia, and Africa. This strategic partnership aims to accelerate iNova's growth strategy through geographic expansion into Southeast and North Asia, leveraging TPG's regional expertise and capital.PR NewswireValeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle GroupValeant Pharmaceuticals International completed the sale of its iNova Pharmaceuticals business to funds managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash. The company will use approximately $920 million in net proceeds to repay term loan debt under its Senior Credit Facility and announced it is on track to exceed its August 2016 commitment to pay down $5 billion in debt before February 2018.PR NewswireValeant Announces Second-Quarter 2017 ResultsValeant Pharmaceuticals International, Inc. reported a GAAP net loss of $38 million for the second quarter of 2017, alongside revenues of $2.233 billion and adjusted EBITDA of $951 million. The company strengthened its balance sheet by selling Dendreon Pharmaceuticals and using proceeds to pay down debt, while announcing agreements to sell iNova Pharmaceuticals and Obagi Medical Products. Valeant updated its full-year revenue guidance range downward but maintained its adjusted EBITDA guidance, citing strong organic growth in its Bausch + Lomb/International and Salix segments.